Pharmaceutical Researcher

Pharmaceutical Researcher

drugstr

Central, NJ

Male, 61

I have worked as a drug discovery scientist for over 30 years performing experiments to help identify novel chemical compounds for their potential in treating diseases in the areas of infection, inflammation and cardiovascular disorders. I have a good familiarity with the entire process from discovery to safety to clinical trials and even marketing. Ask me about the business of Big Pharma. I’m happy to comment on any and all hot-button issues. My opinions are quite often not pro-business.

SubscribeGet emails when new questions are answered. Ask Me Anything!Show Bio +

Share:

Ask me anything!

Submit Your Question

41 Questions

Share:

Last Answer on July 29, 2020

Best Rated

Will there be a cure for cancer in this lifetime?

Asked by fingX over 8 years ago

If by cure you mean cancer being no more serious than a sore throat then no, not in this or any future lifetime. Cancer will always be a complicated condition that will require accurate diagnosis, careful characterization, appropriate treatment and exhaustive monitoring. As you know there are some cures already. Some cancers are successfully treated with surgery. Bone marrow transplants work for some leukemias. And targeted therapies, molecules or antibodies that are designed to be killers of very specific types of cancer cells, are emerging. One in particular has been on the market for over 10 years. It works, but the downside is its specificity. It only works on a few types of cancers. That’s not to say that progress isn’t being made. With each passing year the chances get better and better that the cancer you may eventually get will be treatable with an effective, targeted therapy that is currently in the pipeline or has yet to be discovered. Advances in cancer will more than likely continue to be a slow, stepwise process.

Why are brand name drugs SOOOOO much more expensive than the generics? Do you think it's justified?

Asked by HaleyOKC over 8 years ago

I have SOOOOO many thoughts on this. I won’t be able to say everything. How’s this for a start? “When you buy a brand name drug you’re not paying for the pill, but rather the intelligence that’s behind it. When you buy a generic drug you’re paying for the pill.” ….. me It’s well known that drug development costs are enormous. It may cost over a billion dollars to bring a new drug to market, but what’s not understood is that as much as ten times that amount may also have been spent at the same time on drug candidates that never make it to market for various reasons. This is the true cost of drug development and the tab must be paid in order for us to continue to enjoy the benefits of better drugs in the future. So in the handful of years in which a company’s patent rights prevail a pill might, for argument’s sake, cost 10 cents to manufacture, sell for 3 dollars, but return a profit of about 30 cents. So on accounting principles this seems justified, but in my opinion, not always. It costs about the same to develop a “me-too” drug as it does to bring forward an innovative one. I’m not talking about generics here, but rather branded drugs that work the same, are chemically related, but different enough to be patentable. Case in point - consider the succession of statins that have appeared over the years. I personally think that it’s unfair for consumers to bear the full cost of copy-cat research since in principle it was largely unnecessary to produce the product and posed a lot less risk to the manufacturer. So all hail generic drug companies for all they do in keeping healthcare costs affordable! No argument there. Keep in mind though that when they sell you that 10 cent pill for a dollar, they’re making a substantially larger profit than the developer. To be fair, that windfall doesn’t last very long. In time, with expiring rights and competition the price will fall to that 30 cent level. Higher prices for branded, innovative drugs are justified so long as pricing is fixed at a level that yields a reasonable return as opposed to charging what the market will bear. In my opinion, high prices for copy-cat drugs are not justified unless they possess a valid, therapeutic advantage over the innovator (ask me more about this). In spite of the lower prices charged by generic companies their profits are often quite substantial because their development costs are virtually nil.

Is it true that pharma companies are more interested in "treating" diseases than actually curing them, given the economic advantages of the former?

Asked by jspot over 8 years ago

Pharmaceutical companies are not sinister enterprises. They are however, opportunistic. When considering where to invest their resources, they look first at the size of the affected population then determine how best to rapidly develop a market. Trust me, if a curative drug target presented itself as the most tractable they would pursue it, not only because it would be the quickest path to market, but it would also be the most competitive. Big Pharma continues to hunt for cures in infectious diseases with drugs and vaccines. Consider the recent registration of drugs for the hepatitis C virus and vaccines for HPV. Targeted anti-tumor drugs are being sought as are gene therapies to correct inborn defects and RNAi technology to modulate errant gene activity. Cures are not off the table so long as they are viable. So why does it appear to many that they are? Let’s face it. There aren’t many examples of cures using medicine alone. I know that sounds weird, but think about it. Other than treatment of infections with antibiotics or prevention with vaccines, what else can be considered a cure? All right, maybe a couple of others – glucocorticoids for some acute inflammatory conditions like rashes, allergen shots and targeted cancer drugs. Line them up against the list of chronic conditions being treated medically and the cures almost disappear in the public eye. The majority of chronic diseases are simply not curable when the underlying causes are damage by aging, abuse or the family gene pool. A word or two about AIDS. The attention given to the HIV problem and its failures is understandable. It is, after all, an infectious disease and as I’ve said, is among the most curable of disease types. Viral diseases are typically best controlled by vaccines, but since HIV interferes with the immune system, a sufficient immune response cannot be mounted to protect the patient. For several reasons, small molecule anti-virals can control HIV, but not eradicate it. So, to the question regarding willingness of Big Pharma to pursue treatments in lieu of cures I say the following. In every advance in HIV drug research scientists focused their efforts on blocking the action of a known, critical component of the virus’ life cycle which, in principle, should have wiped it out. To be sure, failure to cure was a disappointment, but was clearly not a design.

Has your company ever released a drug it wasn't sure was safe? How can you ever really be sure?

Asked by KennyGeeeeeee over 8 years ago

No drug is safe. There are safety concerns with every medicine on the market. One of the requirements for approval of a new medicine by the FDA is for the drug company to reveal at what dose level the probable toxicities will appear and to prove that the doses used in therapy will be far lower. That means that the drug companies will push the safety envelope in animal studies to determine what bad things might happen.[Sounds cruel, but it’s not. Readouts are no worse than you having lab tests done on your blood.] Prescribers are then required to inform patients about the particular risks and monitor the patient during therapy if necessary. That’s as sure as you can be. The issue with drug safety is not so much the safety itself, but rather the transparency in publicizing the information. Complete and accurate disclosure is crucial in determining benefit versus risk. My company has indeed had public issues of this kind, but to my knowledge it did not deliberately put patients at risk. It happens quite often that actionable safety issues are only recognized after a drug had been widely prescribed. Inevitably in these matters controversy is generated along with civil and criminal investigations. It’s messy but necessary for improving the regulatory system that protects us.

At a pharma company, is there any "classism" amongst different kinds of scientists or different areas of research? (Kinda like how doctors look down upon chiropractors?)

Asked by jsb over 8 years ago

In some companies there’s a strict dichotomy between PhD and non-PhD researchers, much like an academic environment. Non-PhDs can only ascend up through a series of “associate” positions and their roles are always in support of a PhD lab head. For PhDs the sky’s the limit in terms of advancement and one could characterize their attitude towards associates as superior. My company has not been like that. While PhDs enter at a higher level, non-PhDs can advance based on merit without restriction. I can think of three, two for whom I’ve worked directly, who achieved very high levels of responsibility and are responsible for some very important medicines. Regarding scientists from different fields I often observe lively interest amongst them. In-house lectures, for example, always draw large audiences and there’s always lots of questions and discussion. Guest lecturers, too, draw crowds of scientists from all fields.

Ever pull any lab pranks (or had one pulled on you)?

Asked by The Joker over 8 years ago

By pranks you mean ‘dead mouse in the secretary’s lunch’ or ‘slipping an inappropriate slide into someone’s presentation’? No, that doesn’t happen where I work now. I remember working in an academic lab in the 70s where a guy tamed a lab rat. He would put it in a drawer or a cabinet or the pocket of his lab coat and watch people freak out when they saw it. He got me once. You can’t do that kind of thing now. There aren’t many gags that you can pull today that wouldn’t violate some ethical, safety, or PC standard.

What countries have the most sophisticated or productive drug development programs?

Asked by Tess over 8 years ago

The US does the most, however a lot of innovative research also goes on in western Europe, particularly in the UK, Switzerland, France and Germany. There’s a large drug company in Israel that does a lot of generic work and some innovative work. In India there are companies that do mostly generic work along with contract work on behalf of western companies. China does a lot of contract work in chemistry and biology and will likely soon become a force in innovative drug development.

Is there a cure for AIDS?

Asked by jspot over 8 years ago

It is well known that there is not. This is assuming that the definition of “cure” is a therapy that, subsequent to its administration, will no longer be necessary. A vaccine would fit this definition, but HIV-vaccine research has failed in several attempts. Nevertheless, some development is still ongoing. Current anti-HIV cocktails are maintenance therapy, probably for life. I say probably because there are a handful of patients that have been “seemingly” cured by them and are being studied. There are also some people who are immune to HIV due to certain genetic factors which are partially understood. One line of research being explored is the genetic modification of a sample of a patient’s own T cells with one of these factors and placing them back in the bloodstream. It’s an interesting concept, but not widely expected to be successful. So there is hope. But if your question is really aimed at revealing a hitherto unknown, secret cure that is being withheld for reasons nefarious, I’ll deal with that in the next question.

Do the scientists at your company interact frequently with the business folks, or are they generally kept in different silos?

Asked by Brickbreak over 8 years ago

Scientists interact infrequently with business partners whose responsibility is handling research budgets and operations. They almost never interact with corporate personnel, sales people and top executives. Higher level scientists will, on occasion, meet with executives representing various functions of the company to discuss experimental medicines and the pipeline portfolio. Silo is a term often used in my company as being undesirable, yet the transformation toward greater and greater specialization, an effort aimed at increasing performance, is only making them taller and narrower.

What's the real story on the relationship between the manufacturers of drugs and the doctors who prescribe them? I had a friend who was a sales rep for a big pharma company and he made it sound like there were some really perverse incentives at play.

Asked by Dr. Nick over 8 years ago

I’m not sure I can answer this question to your satisfaction. Sounds like you may have more information about this than I do. I may be an insider, but not so deep that I rub elbows with the field people. I’ve met a few at scientific meetings and I have observed the manner in which they host some of the physician attendees - not really very extravagant. The number of sales people has dwindled dramatically in recent years due marketing changes which emphasize sales to HMO and Pharmacy Benefit Managers who are now the largest customers. I’ve heard in the past about vacation junkets offered to medical opinion leaders and their families on which medical matters were discussed for all of about an hour so as to legally pass it off as a business trip. A practice recently disclosed in which eminent physicians publish favorable articles, doubtless in exchange for some consideration, that were actually written by drug company scientists. As far as rewarding prescribing physicians directly, I don’t know how companies would be able to enumerate the scripts these days given the privacy laws and the layers of drug distribution that currently exist.

Do you think makers of generics should be paying some kind of royalties to whichever company actually put in the R&D to make the original drug? Has this ever been considered at the gov't level? Kinda seems like the right thing to do.

Asked by goalie87 over 8 years ago

To my knowledge, nothing like that has ever been proposed. We all understand the ethics of acknowledging our sources, but this is business and with no financial return this just can’t happen. Big Pharma knows the rules and is structured to play by them. It might interest you to know that there have been cases where the extreme opposite occurs. The former patent holder pays the generic company NOT to sell the drug. I won’t go into how this situation can arise (a bit complicated), but the ‘why’ is obvious (maintain profits). Legal anti-competitiveness is one of the things that gives Big Pharma a bad name.

What do you consider to be your greatest accomplishment in the field?

Asked by erm81 over 8 years ago

Ask that question to any pharmaceutical scientist and he/she will tell you that it’s the part played in contributing to the development of a marketed drug, particularly a life-saving one. In my own experience about 20 years ago I made some critical contributions to the discovery of a drug for the treatment of a somewhat rare, often deadly, lung infection. At the time, the only treatment available was not only frequently unsuccessful, but invariably caused severe, adverse side effects. Before large clinical trials of this drug were begun, the FDA allowed us to treat 60 “salvage” patients, i.e. people who failed standard-of-care therapy and were most likely destined to die. Our treatment saved all but 3 of them and the FDA quickly approved the drug for use in salvage therapy and soon after became the new standard-of-care for this condition. I can honestly say that the award I won for my efforts means less to me than the memory of my participation in that successful, life-saving project.

Sounds like the animal studies you mentioned are humane. But was there ever an instance where you felt like one of your experiments WASN'T totally humane?

Asked by BigBenStl over 8 years ago

Yes, it happens. The USDA considers humane treatment as handling resulting in sensation no worse than a brief needle stick. Experiments are designed to adhere to this standard. However, there are situations, for example the first time a prospective medicine goes from the test tube into an animal, where an unanticipated toxic reaction may occur. When such a reaction occurs the animal is humanely euthanized immediately. There are exceptions to the standard in which some models of disease produce additional discomfort. For all animal experiments, an investigator must submit the intended experimental procedures to an expert review committee for approval. This committee, comprised of in-house scientists, veterinarians and community volunteers, monitors the experimental activities with particular interest in assuring that in these exceptional models, animals endure the least amount of discomfort in order to satisfy the scientific objective.

Are there any widely-known diseases that you think science is right on the brink of curing as of today?

Asked by goalie87 over 8 years ago

When I think of cures I think of vaccines. Here’s a link I found on a search. http://www.news-medical.net/news/20100910/395-new-vaccines-being-developed-for-infectious-diseases-PhRMA.aspx which illustrates hundreds of vaccine programs in the works targeting all sorts of infectious agents. Current therapies for many of them like tuberculosis, MRSA, herpes and malaria are tough to take or only weakly effective.

Do you think that Big Pharma companies that hold exclusive rights to important medicines have a moral obligation to provide them to third world countries at reduced cost or free of charge?

Asked by Dr. Nick over 8 years ago

I agree with you. Your example of AIDS drugs donated, sold at cost or licensed for free is an extreme example of pharma’s mission of fulfilling unmet medical needs. As you know, what you describe is actually happening although it took a bit of negotiating to get control of it. There are a lot of unlicensed generics of all kinds of drugs being manufactured worldwide and it’s a problem that pharma cannot ignore. I say extreme because this same moral obligation extends to the distribution of medicines to countries around the world who’s governments regulate prices. Companies sell drugs in Canada for less because the Canadian government demands it. What choice do they have but to accept these market conditions in order to fulfill that mission? Pharma gets an undeserved bad rap for this from US consumers. It’s strange that no one speaks on their behalf on this. Yes, Big Pharma is a business driven by profits, but willingness to take a hit for moral reasons is good business and they know it.

How do drug companies get people to sign up for experimental drugs? Do they just pay them a lot of money?

Asked by p.t. 007 over 7 years ago

Not having worked directly in clinical operations I don’t know all the particulars regarding patient recruitment for experimental drug trials, but I can give you some general information. There are two types of trials. The first is an initial experiment with certifiably healthy volunteers to observe properties of the drug once administered and to identify any safety and tolerability issues that might be present. Also, if possible, researchers will test for the drug’s access to the desired molecular target. The patients in these trials are often treated and observed in an in-patient hospital-like setting where they are closely monitored for at least a day, fed a controlled diet and repeatedly sampled for blood and possibly other specimens. They are also often called back for control tests. The incentive for participation is cash. Given the intensity of this commitment, payment is significant. I can’t tell you how much, but I would imagine it to be scaled based on geography, length of study and historical rates. Past participants are often invited back and new recruits are obtained through the most efficient local channels. The second type, and by far the largest in terms of participants, is an efficacy trial in which people with the targeted illness are treated and evaluated. The incentive for participation is free treatment, however involved that may be, and of course the medical benefit offered. Some compensation may be available to cover incidental expenses. The commitment is usually not more involved than taking the medication, reporting your experience and periodic visits to the clinic.

What drove you to spend your career in this industry? Is it fulfilling?

Asked by scigeek52 over 8 years ago

In college I was aware that my professors not only taught classes, but also had laboratories in which they did the research which advanced their reputations and contributed new knowledge to science. I thought, “Who wouldn’t be attracted to this noble endeavor?”, and soon found my way into my organic chemistry professor’s lab working alongside PhDs and graduate students. I learned a lot, performed well, enjoyed the collegial experience and within a semester had accomplished work worthy of publication. I was hooked. I had begun my research career. In advancing from chemistry to biology to drug research one overall concept has continued to provide fulfillment for me. That is, when you do research, you have the opportunity to be the first person on earth to behold a new bit of knowledge. It may only be a small piece of information, but you’re the first and it’s yours to own and report. I’m still hooked.

Do pharmaceutical companies pay well? Any special perks worth mentioning?

Asked by N8 over 8 years ago

I would say they pay pretty well. A researcher with a Master’s degree and 5 or more years of experience might earn 90 ± 20k and PhDs 10 to 20k more. In New Jersey, it’s a little tough for a single bread-winner, but for a two salary household it’s comfortable. High level scientists and managers make a lot more. Attaining those positions by advancement has become increasingly difficult. You’d be better off changing employers. There are comprehensive benefit packages including pension and savings plan with matching contributions. No special perks other than free company medicines through the prescription plan. High level exposure to science and medicine is a plus. I’ve met Nobel Laureates and other top scientists and the overall awareness of medical conditions and progress has clearly benefitted my own health and my family’s.

Oh, also I want to know how you make a pill "time-release"? Do you coat it with something special? And more importantly, does it MATTER if a vitamin is delivered in a time-controlled way?
Thanks!

Asked by Brit almost 7 years ago

You are exactly right. A modern pill is actually a cluster of thousands of tiny pills. Each of these tiny pills is engineered to release their contents in a controlled way based on the chemical properties of the drug in order to optimize the therapeutic benefit. Most time-release formulations contain two types, one that dissolves immediately and one that releases slowly or only in another part of the GI tract. With regard to vitamins, most nutritionists are not convinced we need supplements at all. We get all we need from a healthy diet. Supplementing a poor diet is like multiplying by zero. Time release is probably not particularly beneficial for vitamins. After all, our natural intake of vitamins is not time released.

OK, weird question but I always wanted to know: how is "street" meth different than drugs like Adderall, which I'm told is just legal amphetamines? Like why do meth addicts look so F'd up - is street meth chemically different / harsher on the body

Asked by METH almost 7 years ago

Chemically they are essentially the same. It’s how they are administered that makes the difference. Adderall is a carefully engineered mixture of the d & l forms of methamphetamine in a ratio designed to produce the desired norepinephrine driven stimulus with a minimum of dopamine euphoria when taken orally. The drug enters the blood slowly, maximizing at 3 hours (standard form) or 7 hours (XR). I’m guessing that street meth is an uncontrolled mixture. When taken at a higher dose either intranasally or by inhalation, peak levels appear in minutes and are thus extremely high. Not only is the dopamine effect profound, repeated exposure will irreversibly damage the nerve cells that are targeted.

How can do Chemist Online ?

Asked by lucymarion almost 7 years ago

I’m not sure I understand the question. If by “Chemist Online” you mean online pharmacies, more specifically those not in compliance with all pharmacy laws and practice standards, and how they get away with that, then the answer is simple ... enforcement. The DEA is on the case, but decide for yourself how well they’re doing. There’s no reason why a legitimate pharmacy cannot operate online in the US just the same as your local drugstore or your mail-order benefit manager. There are some. Those are the ones sanctioned by the NABP, the National Association of Boards of Pharmacy and licensed by the state in which they operate. Most are not.

How much does potency vary from pill to pill in the same RX batch? I take Adderall, and I'd say 10% of the pills I take I barely 'feel' at all...is it normal for some pills to simply have lower dosages in them?

Asked by Brit almost 7 years ago

My understanding of the acceptable limits of variation in dosage units is specified for each drug as part of the FDA review process. The range limit is typically 80% to 130% of targeted content. In order to guarantee keeping within that range the manufacturer will shoot for statistical variation of no more than 10% and may bump a little to the higher end to increase shelf life. I could not say for sure if the possible variation in Adderall content could be therapeutically detectable as you suggest, but it would not be expected based on general pharmacological principles. That said it remains possible.

What's the difference between your job and pharmacologist?

Asked by David over 5 years ago

Not a big difference.  Broadly defined, a pharmacologist studies the behavior of drugs in the body.  That ranges from where the drug goes, how it leaves and how well it interacts with its target.  Once determined in humans to behave satisfactorily, medical folks take over (clinicians) to evaluate disease efficacy.  For example, the pharmacologist determines how well it lowers cholesterol.  The clinician determines how well it treats heart disease.  As a prerequisite to human studies, my role as an analytical biochemist in early drug discovery supported studies of pharmacology in animals.  I measured drug levels in samples as well as biomarkers related to the action of the drugs.

I would like to do the same job. How many years am I going to have to go to school? When will I start actually working? Is the salary good? What am I going to do mostly?

Asked by Katy over 5 years ago

My advice to you is to first not think of this “job” as a job, but rather as a career.  By that I mean consider that most pharmaceutical research is broadly science based. Don’t limit your thinking to the biology examples that I described.  You can be a chemist or a statistician or even a doctor.  Go to a university with a strong science reputation and get a B.S. in biology, chemistry or math.  Decide where your strengths and passions lie and follow them.  The list is long of things you can major in. There’s biochemistry, physiology, microbiology, cell biology, genetics, synthetic chemistry, analytical chemistry, statistics, animal science, etc.  My recommendation is to go to graduate school for a masters or a PhD or alternatively get a job in an academic lab. Develop your skills, expertise and reputation.  Then seek your high paying job in industry.  The more experience and credentials that you bring to the table, the more influence you will have on choosing the work that you do.  If you get a job right after college it will be just a “job” and your responsibilities will be task oriented.  Come in with expertise, be it technical or academic, you will be project oriented.  That’s where the rewards are.

I'm torn between Physical Therapy and Biotechnology/Bioengineering. I was wondering what I could do with a Masters in Biotech & entrepreneurship? could I potentially conduct research while focusing on the business aspects of biotech?

Asked by PT WannaBE over 5 years ago

I don’t know what kind of career advice I could give you.  PT and biotech seem rather disconnected.  Bioengineering could serve you in developing therapeutic devices.  Most scientists turned entrepreneurs often stay involved in research in a management role and provide intellectual input as well.

I've heard some people say food and drug industries use ingredients in their products that actually promote obesity (additives that are addictive) and illness, because if there were no sick people these huge industries would go bust. What do you say?

Asked by mcmjuly over 5 years ago

Nonsense.

I definitely know I want a career as a pharmaceutical researcher working at a BigPharma company. I am thinking of pursuing a PharmD/PhD dual degree, but have many people arguing that I only need one of the degrees or the other. What are your thoughts

Asked by RLS over 5 years ago

Pharma executives LOVE credentials! They generally tend to be quite risk averse so multiple certifications induce greater confidence in a hiring manager’s decision to support the candidacy of an individual. It sort of lessens the burden of accountability (ass covering). Of course this is not a sound principle as it often leads to failure. Nevertheless, more diplomas might get you the interview, particularly in this era of downsizing and reorganizing. I am not advocating that you seek a dual degree for that reason.  I don’t know anyone with a PharmD/PhD dual degree and I’m not quite sure where such a person would fit in my company. In the lab environment in which I operate PhDs typically are the project leaders with some MDs in that role. No PharmDs. In the clinical areas it’s all MDs. A PharmD in my company might find a role in Drug Metabolism, Safety Assessment or Regulatory Affairs or maybe even Marketing. So it really depends on what you want to do. If you want to discover new drugs at the bench, get the PhD and become a subject matter expert. I would argue that your research project for the dual degree may not train you adequately for discovery research. If you’re more interested in taking new discoveries forward to the clinic the dual degree might be helpful. 

Also, how difficult would it be to get into a graduate bioengineering program with an A.S. in biotech and a Bsc in clinical lab science?

Asked by PT WannaBE over 5 years ago

I am not an academic so I can’t say one way or another if you would qualify.  My guess is that you might find a place, but may have to take a more extensive set of basic courses in order to elevate yourself to the level of other students in the program.

I am very interested in getting in to clinical trials. Entry document review to begin. I have a B.S. Business Administration con Healthcare Management and currently MBA con Health Services Administration. What are your suggestions to get in the field

Asked by Kim over 4 years ago

This is really not in my wheel house, but I’ll tell you what I think I know. Clinical researchers in big pharma are typically MDs. They interface between scientific groups in house and outside physicians who run the trials. They have a non-MD support staff which is more or less a dead end. One simply can’t advance without an MD. This sort of work does not fit with your business training. Surely, clinical research has a management arm, but I’m sorry, I can’t tell you how to get there. Increasingly, big pharma tends to outsource a lot of their clinical work to CROs (contract research organizations). Search for them. Breaking in to the business end of one of these might be easier since they are smaller, growing and adapting. Down the road you might be able to network to something bigger and better. Hope this helps.

Where in the drug research process do companies apply for patents?

Asked by Aceso Under Glass over 4 years ago

Initial patent applications are filed early in the discovery process. As soon as a novel chemical structure is identified as having pharmacological properties a very lengthy, general application is authored that claims therapeutic benefits for every conceivably related medical condition and includes every imaginable chemical modification to that structure. During the development process additional patents might be filed for hitherto unexpected uses and for novel formulation and manufacturing processes.

What do you think of Alex Jones take on big pharma?

Asked by Martian about 1 month ago

I can't answer because I pay no attention to him.

Hello, what is best for COVID-19? So there is that hydroxychloroquine, vaccines, UV light, and other things like that. I also assume Trump did not mean inject Lysol what did he mean?

Asked by Samantha about 1 month ago

Trump spoke without thinking - disinfectants are poisons. Hydroxychloroquine was a silly attempt at being a hero. A swing and a miss, not a home run. Your question is vague. Are you asking about killing the virus in the air or on surfaces, or how to best avoid infection, or what's the best treatment for the disease? Answers to the first two are described in the media daily, as for the last my opinion is oxygen, anti-inflammatories and an appropriate anti-viral (not yet invented).

I am taking dicyclomien and Osphena together. Since I've started the Osphena my IBS (just swelling and pressure) is uncontrollable even with the meds. Do these two medicines have something in them to make them not work?

Asked by Ashley over 2 years ago

Sorry for the late response. I have no expertise in this area. I hope by now you have resolved your issue. Best of luck.

Hello, I have a dream of someday being the owner of a company that sells a drug that temporarily disables or dulls the taste buds for weight loss and health benefits. My question is, is it possible to do this?

Asked by Skyy about 2 years ago

Sorry for the late response. I believe that taste is not the major driver of appetite. In fact, dulling the senses might encourage further eating. Just my 2 cents.

I was accepted into a 6 year straight Pharm.D. program right out of high school, and I am hoping that I can use this degree to become a research scientist. Will a Pharm.D. satisfy my career goal?

Asked by Nitin about 4 years ago

Sorry for the late response. I hope you're doing well and enjoying the program. I think that your training would prepare you well for your goal. I have seen Pharm. D.s working at all levels, but I must say that research leadership tends to be composed mainly of PhDs and MDs. Still, your success will depend entirely on your skills and ambition. Good luck!

I am talking to someone online who claims to be a pharmaceutical researcher
What is a good ? To ask to find out if they are being truthful please

Asked by Sam 26 days ago

Ask the person about the last presentation that he or she made and to send you a copy of the slide deck. If you receive it, look it over and ask questions about it. You'll be able to tell from the answers whether he/she is legit.

What do you think of Trump sidelining Fauci?

Asked by Jake 21 days ago

Not really a pharma question. From a drug treatment perspective only I would say that perhaps it's better that we get messages from Fauci in the media rather than from the White House briefing room.

What did you think of Trumps speech today?

Asked by Angry redneck 18 days ago

Again, not really a pharma question. Fact checking notwithstanding, the speech was his version of events, status of the pandemic, and his importance. Nothing new. Regarding pharma, he did know that there are two treatments that have demonstrated clinical benefit.

Why do you hate Trump?

Asked by Mickey 12 days ago

Not a pharma question.

It is because you attack him so you must have a reason

Asked by Mickey 11 days ago

Not a question.

What do you think of this video?
https://www.bitchute.com/video/HeC0tHZDX7dk/

Asked by Kathleen 7 days ago